Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crosstalk between receptor tyrosine kinases (RTKs) and G protein-coupled receptors (GPCR) in the brain: Focus on heteroreceptor complexes and related functional neurotrophic effects
Valentina Di Liberto, Giuseppa Mudò, Natale Belluardo
Neuropharmacology (2018) Vol. 152, pp. 67-77
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

FGF/FGFR signaling in health and disease
Yangli Xie, Nan Su, Jing Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 598
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 96
Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
Ruiwen Ruan, Li Li, Xuan Li, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 52
Fibroblast Growth Factor Receptor Functions in Glioblastoma
Ana Jimenez‐Pascual, Florian A. Siebzehnrübl
Cells (2019) Vol. 8, Iss. 7, pp. 715-715
Open Access | Times Cited: 100
The role of neurotrophic factors in novel, rapid psychiatric treatments
Jihye Kim, Michelle He, Alina K. Widmann, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 227-245
Closed Access | Times Cited: 25
Molecular crosstalk between GPCR and receptor tyrosine-protein kinase in neuroblastoma: molecular mechanism and therapeutic implications
Kousik Maparu, Dhrita Chatterjee, Ramandeep Kaur, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access | Times Cited: 1
Transactivation of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs): Recent insights using luminescence and fluorescence technologies
Laura E. Kilpatrick, Stephen J. Hill
Current Opinion in Endocrine and Metabolic Research (2020) Vol. 16, pp. 102-112
Open Access | Times Cited: 65
Cross-Talk between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins
Marta Latko, Aleksandra Czyrek, Natalia Porębska, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 455-455
Open Access | Times Cited: 64
Nongenetic engineering strategies for regulating receptor oligomerization in living cells
Jingying Li, Liping Wang, Jin‐Miao Tian, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 5, pp. 1545-1568
Closed Access | Times Cited: 61
TSH/IGF1 receptor crosstalk: Mechanism and clinical implications
Christine C. Krieger, Susanne Neumann, Marvin C. Gershengorn
Pharmacology & Therapeutics (2020) Vol. 209, pp. 107502-107502
Open Access | Times Cited: 54
Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer
Jing Wang, Jing Wei, Tianjie Pu, et al.
Cell Reports Medicine (2024), pp. 101388-101388
Open Access | Times Cited: 5
Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs
Aleksandra Gędaj, Paulina Gregorczyk, Dominika Żukowska, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 77, pp. 39-55
Open Access | Times Cited: 5
Protein Tyrosine Kinase 7 Regulates EGFR/Akt Signaling Pathway and Correlates With Malignant Progression in Triple-Negative Breast Cancer
Naipeng Cui, Shu Bin Qiao, Shan Jiang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 28
Central nervous system interaction and crosstalk between nAChRs and other ionotropic and metabotropic neurotransmitter receptors
Federica Bono, Chiara Fiorentini, Veronica Mutti, et al.
Pharmacological Research (2023) Vol. 190, pp. 106711-106711
Open Access | Times Cited: 11
Biased signaling in drug discovery and precision medicine
Ren-Lei Ji, Ya‐Xiong Tao
Pharmacology & Therapeutics (2025), pp. 108804-108804
Closed Access
Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward
Mackenzie C. Gamble, Benjamin R. Williams, Navsharan Singh, et al.
Frontiers in Systems Neuroscience (2022) Vol. 16
Open Access | Times Cited: 17
Manipulation of HSP70-SOD1 Expression Modulates SH-SY5Y Differentiation and Susceptibility to Oxidative Stress-Dependent Cell Damage: Involvement in Oxotremorine-M-Mediated Neuroprotective Effects
Miriana Scordino, Monica Frinchi, Giulia Urone, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 687-687
Open Access | Times Cited: 10
Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents
Mirjana Antonijevic, Despoina Charou, Audrey Davis, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 515-515
Open Access | Times Cited: 3
Receptor tyrosine kinases activate heterotrimeric G proteins via phosphorylation within the interdomain cleft of Gαi
Nicholas A. Kalogriopoulos, Inmaculada López-Sánchez, Chang‐Shen Lin, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 46, pp. 28763-28774
Open Access | Times Cited: 27
EGFR Signaling Causes Morphine Tolerance and Mechanical Sensitization in Rats
Stéphanie Puig, Courtney L. Donica, Howard B. Gutstein
eNeuro (2020) Vol. 7, Iss. 2, pp. ENEURO.0460-18.2020
Open Access | Times Cited: 25
Tea combats circadian rhythm disorder syndrome via the gut-liver-brain axis: potential mechanisms speculated
Shanshan Hu, Liyong Luo, Liang Zeng
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 24, pp. 7126-7147
Closed Access | Times Cited: 15
The role of EGFR in vascular AT1R signaling: From cellular mechanisms to systemic relevance
Michael Gekle, Virginie Dubourg, Gerald Schwerdt, et al.
Biochemical Pharmacology (2023) Vol. 217, pp. 115837-115837
Open Access | Times Cited: 9
Inhibition of TSH/IGF-1 Receptor Crosstalk by Teprotumumab as a Treatment Modality of Thyroid Eye Disease
Christine C. Krieger, Xiangliang Sui, George J. Kahaly, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 4, pp. e1653-e1660
Open Access | Times Cited: 20
Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia—Relevance for Mental Diseases
Dasiel O. Borroto‐Escuela, Patrizia Ambrogini, Manuel Narváez, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1902-1902
Open Access | Times Cited: 18
How cells sense and integrate information from different sources
Maria F. Ullo, Lindsay B. Case
WIREs Mechanisms of Disease (2023) Vol. 15, Iss. 4
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top